Alliancebernstein L.P. Tg Therapeutics, Inc. Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

A detailed history of Alliancebernstein L.P. transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 193,570 shares of TGTX stock, worth $5.72 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

193,570

Previous 161,870 19.58%

Holding current value

$5.72 Million

Previous $2.88 Million 57.24%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$17.21 - $25.28 $545,557 - $801,376	31,700 Added 19.58%	193,570 $4.53 Million
Q2 2024 Aug 14, 2024	SELL	$13.32 - $19.19 $71,262 - $102,666	-5,350 Reduced 3.2%	161,870 $2.88 Million
Q4 2023 Feb 14, 2024	BUY	$6.68 - $18.81 $29,392 - $82,764	4,400 Added 2.7%	167,220 $2.86 Million
Q2 2023 Aug 15, 2023	BUY	$15.48 - $35.0 $80,805 - $182,700	5,220 Added 3.31%	162,820 $4.04 Million
Q1 2023 May 15, 2023	SELL	$10.23 - $19.34 $23,529 - $44,482	-2,300 Reduced 1.44%	157,600 $2.37 Million
Q4 2022 Feb 14, 2023	BUY	$5.01 - $11.83 $15,030 - $35,490	3,000 Added 1.91%	159,900 $1.89 Million
Q1 2022 May 13, 2022	SELL	$7.81 - $20.45 $472,895 - $1.24 Million	-60,550 Reduced 27.85%	156,900 $1.49 Million
Q4 2021 Feb 14, 2022	SELL	$15.2 - $35.51 $314,199 - $734,027	-20,671 Reduced 8.68%	217,450 $4.13 Million
Q3 2021 Nov 10, 2021	BUY	$21.78 - $40.45 $150,695 - $279,873	6,919 Added 2.99%	238,121 $7.93 Million
Q2 2021 Jul 30, 2021	BUY	$32.5 - $48.96 $417,690 - $629,233	12,852 Added 5.89%	231,202 $8.97 Million
Q1 2021 May 06, 2021	SELL	$41.61 - $54.3 $2.61 Million - $3.41 Million	-62,734 Reduced 22.32%	218,350 $10.5 Million
Q4 2020 Feb 08, 2021	BUY	$25.27 - $54.9 $1.64 Million - $3.56 Million	64,884 Added 30.01%	281,084 $14.6 Million
Q3 2020 Nov 12, 2020	SELL	$18.49 - $27.24 $62,200 - $91,635	-3,364 Reduced 1.53%	216,200 $5.79 Million
Q2 2020 Aug 13, 2020	BUY	$8.9 - $21.84 $984,909 - $2.42 Million	110,664 Added 101.62%	219,564 $4.28 Million
Q1 2020 May 14, 2020	SELL	$7.14 - $15.99 $10,995 - $24,624	-1,540 Reduced 1.39%	108,900 $1.07 Million
Q2 2019 Aug 14, 2019	SELL	$6.27 - $8.65 $76,494 - $105,530	-12,200 Reduced 9.95%	110,440 $955,000
Q4 2018 Feb 13, 2019	BUY	$3.44 - $5.76 $137,944 - $230,976	40,100 Added 48.58%	122,640 $503,000
Q3 2018 Nov 08, 2018	BUY	$5.15 - $14.0 $102,485 - $278,600	19,900 Added 31.77%	82,540 $462,000
Q2 2018 Aug 13, 2018	BUY	$12.5 - $15.0 $33,750 - $40,500	2,700 Added 4.5%	62,640 $824,000
Q3 2017 Nov 13, 2017	BUY	$10.0 - $12.7 $599,400 - $761,238	59,940	59,940 $710,000

Others Institutions Holding TGTX

# of Institutions

338

Shares Held

88.3M

Call Options Held

2.35M

Put Options Held

1.7M

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.29B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Tg Therapeutics, Inc. Transaction History